Ultra-Low Radiation PET Imaging Study for Brain Scanning
Part of Brain & nervous system, Cancer clinical trials.
This study tests a new way to take brain imaging scans (PET scans) using a very small amount of radioactive tracer. Researchers want to see if they can get clear pictures of your brain while reducing your radiation exposure compared to standard scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You can understand the study and agree to follow all study procedures
- If you are a woman who could become pregnant, you must have a negative pregnancy test before the scan
- You have not had more than 4 prior enrollments in this same study
- You have not exceeded the safe annual radiation limit (50 mSv) from research scans in the past year
- You can lie still in an enclosed scanning machine without severe anxiety or pain
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to take PET scan pictures using a very low amount of a radioactive tracer that targets a protein called SSTR2. It is designed to see if these scans can work well while reducing radiation exposure for patients with certain types of tumors.
This study tests if a very low dose of a standard PET scan tracer (FDG) can produce clear images. It may help people who need a PET scan but are concerned about radiation exposure.
This study tests whether using a very low dose of radiation for a brain PET scan can still give clear images. If you are eligible, you will get a type of radioactive tracer that helps show amyloid plaques in the brain, often used in Alzheimer's research.
This trial tests a very low dose of a radioactive tracer (18F-flurpiridaz) for PET scans of the heart. It aims to see if using less radiation still produces clear images, which may be safer for patients who need repeated scans.
This study tests a new radioactive dye called [18F]GATT-44 to see how well it can show a specific brain protein on a PET scan. It may help researchers better understand brain conditions in the future.
This study tests a very low-dose PET scan to see if it can find prostate cancer cells that have PSMA on their surface. It might help you avoid higher radiation doses while still getting important images.
Hear when a new Parkinsonian Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.